Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients (CAMA-2)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2011 by Central Texas Neurology Consultants.
Recruitment status was  Not yet recruiting
Study NCT01333358   Information provided by Central Texas Neurology Consultants

First Received on April 8, 2011.   Last Updated on April 22, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial